99 related articles for article (PubMed ID: 25738465)
21. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies.
Le Large TYS; Bijlsma MF; Kazemier G; van Laarhoven HWM; Giovannetti E; Jimenez CR
Semin Cancer Biol; 2017 Jun; 44():153-169. PubMed ID: 28366542
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic Silencing of GNMT Gene in Pancreatic Adenocarcinoma.
Botezatu A; Bleotu C; Nastase A; Anton G; Bacalbasa N; Duda D; Dima SO; Popescu I
Cancer Genomics Proteomics; 2015; 12(1):21-30. PubMed ID: 25560641
[TBL] [Abstract][Full Text] [Related]
23. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
24. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
25. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.
Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393
[TBL] [Abstract][Full Text] [Related]
26. LINC00342 induces metastasis of lung adenocarcinoma by targeting miR-15b/TPBG.
Su H; Yu S; Sun F; Lin D; Liu P; Zhao L
Acta Biochim Pol; 2022 Apr; 69(2):291-297. PubMed ID: 35452205
[TBL] [Abstract][Full Text] [Related]
27. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M
Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862
[TBL] [Abstract][Full Text] [Related]
29. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
Zhu Z; Xu Y; Du J; Tan J; Jiao H
J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773
[TBL] [Abstract][Full Text] [Related]
30. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
[TBL] [Abstract][Full Text] [Related]
33. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
34. A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.
Liu W; Zhang B; Hu Q; Qin Y; Xu W; Shi S; Liang C; Meng Q; Xiang J; Liang D; Ji S; Liu J; Hu P; Liu L; Liu C; Long J; Ni Q; Yu X; Xu J
Int J Oncol; 2017 May; 50(5):1792-1800. PubMed ID: 28350132
[TBL] [Abstract][Full Text] [Related]
35. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.
Steele CW; Oien KA; McKay CJ; Jamieson NB
Pancreas; 2011 Nov; 40(8):1165-71. PubMed ID: 22001830
[TBL] [Abstract][Full Text] [Related]
36. HMGN5 promotes proliferation and invasion via the activation of Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma.
Zhao J; Wang Y; Wu X
Oncol Lett; 2018 Sep; 16(3):4013-4019. PubMed ID: 30128022
[TBL] [Abstract][Full Text] [Related]
37. FOXO3 is essential for CD44 expression in pancreatic cancer cells.
Kumazoe M; Takai M; Bae J; Hiroi S; Huang Y; Takamatsu K; Won Y; Yamashita M; Hidaka S; Yamashita S; Yamada S; Murata M; Tsukamoto S; Tachibana H
Oncogene; 2017 May; 36(19):2643-2654. PubMed ID: 27893718
[TBL] [Abstract][Full Text] [Related]
38. Phenotype of TPBG Gene Replacement in the Mouse and Impact on the Pharmacokinetics of an Antibody-Drug Conjugate.
Hu G; Leal M; Lin Q; Affolter T; Sapra P; Bates B; Damelin M
Mol Pharm; 2015 Jun; 12(6):1730-7. PubMed ID: 25423493
[TBL] [Abstract][Full Text] [Related]
39. Trophoblast glycoprotein: possible candidate mediating podocyte injuries in glomerulonephritis.
Murakami T; Abe H; Nagai K; Tominaga T; Takamatsu N; Araoka T; Kishi S; Takahashi T; Mima A; Takai Y; Kopp JB; Doi T
Am J Nephrol; 2010; 32(6):505-21. PubMed ID: 20980737
[TBL] [Abstract][Full Text] [Related]
40. Epigenomic Changes Prime PDAC Metastasis.
Cancer Discov; 2017 Apr; 7(4):OF3. PubMed ID: 28232366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
